Does NIVOLUMAB Cause Hypophysitis? 755 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 755 reports of Hypophysitis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.9% of all adverse event reports for NIVOLUMAB.
755
Reports of Hypophysitis with NIVOLUMAB
0.9%
of all NIVOLUMAB reports
58
Deaths
485
Hospitalizations
How Dangerous Is Hypophysitis From NIVOLUMAB?
Of the 755 reports, 58 (7.7%) resulted in death, 485 (64.2%) required hospitalization, and 85 (11.3%) were considered life-threatening.
Is Hypophysitis Listed in the Official Label?
Yes, Hypophysitis is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hypophysitis?
IPILIMUMAB (981)
PEMBROLIZUMAB (411)
CARBOPLATIN (144)
ATEZOLIZUMAB (125)
PACLITAXEL (110)
BEVACIZUMAB (61)
DURVALUMAB (60)
PEMETREXED (51)
CYCLOPHOSPHAMIDE (38)
LENVATINIB (32)
Which NIVOLUMAB Alternatives Have Lower Hypophysitis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE